Pfizer tests insulin inhaler:
This article was originally published in Clinica
Executive Summary
Pfizer has started a multicentre trial of insulin inhaler therapy. The inhaler will be tested in 240 patients and has earned Inhale Therapeutic Systems a $5 million equity investment from Pfizer.